Breast cancer can be grouped into different subtypes, where expression of the estrogen receptor (ER) and amplification of human epidermal growth factor receptor 2 (HER2) are important markers for selecting hormonal therapy or therapies targeting HER2 [1]. Here, ERBB2 is linked to breast carcinoma.